These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6839514)

  • 21. Antihypertensive effect of a novel calcium antagonist, SD-3211, in experimental hypertensive rats.
    Takada T; Miyawaki N; Kageyama M; Matsuno K; Ishida N; Yamauchi H; Iso T
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):855-62. PubMed ID: 1725898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydralazine reduces elevated sleep apnea index in spontaneously hypertensive (SHR) rats to equivalence with normotensive Wistar-Kyoto rats.
    Carley DW; Trbovic SM; Radulovacki M
    Sleep; 1996 Jun; 19(5):363-6. PubMed ID: 8843525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic comparison of diltiazem and TA-3090 in spontaneously hypertensive and normal Wistar-Kyoto rats.
    Isshiki T; Pegram BL; Frohlich ED
    Am J Cardiol; 1988 Oct; 62(11):79G-84G. PubMed ID: 3177230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between cardiovascular hypertrophy and cardiac baroreflex function in spontaneously hypertensive and stroke-prone rats.
    Minami N; Head GA
    J Hypertens; 1993 May; 11(5):523-33. PubMed ID: 8390524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different antihypertensive effects of nifedipine in conscious experimental hypertensive and normotensive rats.
    Ishii H; Itoh K; Nose T
    Eur J Pharmacol; 1980 May; 64(1):21-9. PubMed ID: 7449813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. Part II.
    Gattu M; Terry AV; Pauly JR; Buccafusco JJ
    Brain Res; 1997 Oct; 771(1):104-14. PubMed ID: 9383013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immediate and prolonged hemodynamic effects of TA-3090 on spontaneously hypertensive (SHR) and normal Wistar-Kyoto (WKY) rats.
    Isshiki T; Pegram BL; Frohlich ED
    Cardiovasc Drugs Ther; 1988 Nov; 2(4):539-47. PubMed ID: 3154632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of ketanserin, verapamil and diltiazem on vascular sympathetic nerve activity in hypertension.
    Tsuda K; Nishio I; Masuyama Y
    Clin Exp Hypertens A; 1989; 11 Suppl 1():435-40. PubMed ID: 2743604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term effects of brief antihypertensive treatment on systolic blood pressure and vascular reactivity in young genetically hypertensive rats.
    Traub O; Lloyd MC; Webb RC
    Cardiovasc Drugs Ther; 1995 Jun; 9(3):421-9. PubMed ID: 8527352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats.
    Karasawa A; Kubo K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1691-4. PubMed ID: 3219141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal and postnatal hydralazine treatment does not prevent renal vessel wall thickening in SHR despite the absence of hypertension.
    Smeda JS; Lee RM; Forrest JB
    Circ Res; 1988 Sep; 63(3):534-42. PubMed ID: 3409485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in rats.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1684-90. PubMed ID: 3064752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium entry blockers: antihypertensive and natriuretic effects in experimental animals.
    Nagao T; Yamaguchi I; Narita H; Nakajima H
    Am J Cardiol; 1985 Dec; 56(16):56H-61H. PubMed ID: 3878075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of long-term treatment with diltiazem on atrial natriuretic peptides in spontaneously hypertensive rats.
    Kohno M; Murakawa K; Yasunari K; Yokokawa K; Kurihara N; Takeda T
    Clin Exp Hypertens A; 1988; 10(5):859-71. PubMed ID: 2972423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response of isolated perfused heart to ischemia after long-term treatment of spontaneously hypertensive rats with diltiazem.
    Obata H; Tanaka H; Haneda T
    Jpn Circ J; 1990 Jan; 54(1):89-99. PubMed ID: 2139706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of renal damage by angiotensin II blockade, accompanied by increased renal hepatocyte growth factor in experimental hypertensive rats.
    Matsumoto K; Morishita R; Moriguchi A; Tomita N; Yo Y; Nishii T; Nakamura T; Higaki J; Ogihara T
    Hypertension; 1999 Aug; 34(2):279-84. PubMed ID: 10454454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular remodeling and improvement of coronary reserve after hydralazine treatment in spontaneously hypertensive rats.
    Anderson PG; Bishop SP; Digerness SB
    Circ Res; 1989 Jun; 64(6):1127-36. PubMed ID: 2524290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal phosphate excretion in spontaneously hypertensive and normotensive Wistar Kyoto rats.
    Hsu CH; Chen PS; Caldwell RM
    Kidney Int; 1984 May; 25(5):785-95. PubMed ID: 6471665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative cardioprotective effects of cromakalim and diltiazem in ischemic hypertrophied rat hearts.
    Grover GJ; Dzwonczyk S; Monticello TM
    Am J Physiol; 1996 Jan; 270(1 Pt 2):H174-82. PubMed ID: 8769749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockade of angiotensin II provides additional benefits in hypertension- and ageing-related cardiac and vascular dysfunctions beyond its blood pressure-lowering effects.
    Demirci B; McKeown PP; Bayraktutan U
    J Hypertens; 2005 Dec; 23(12):2219-27. PubMed ID: 16269964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.